Change how you see cancer data, change the world. Cancer Research Reports from USA Cancer Research Reports from Japan Clinical Trial Data from Germany Cancer Data from Brazil Cancer Data from China Cancer Data from Spain Cancer Data from Denmark Clinical Trial Data from France Cancer Data from Argentina Clinical Trial Data from Australia Cancer Research Reports from Italy Cancer Research Reports from Canada Cancer Research Reports from India Cancer Research Reports from the United Kingdom Cancer Research Reports from Taiwan Cancer Data from Mexico Clinical Trial Data from the Netherlands Cancer Data from Poland Cancer Data from Sweden Cancer Research Reports from South Korea Cancer Data from Finland Clinical Trial Data from Norway Cancer Data from Russia Cancer Data from Russia Clinical Trial Data from France Detailed epidemiology data for the world’s leading cancer markets.

With the EpicOncology™ data platform, you have one of the world’s most comprehensive sources of global cancer epidemiology data. Use it to forecast cancer trends…and develop lifesaving treatments faster.


More than just data. See clearly into the future of cancer trends with hands-on service & expert support.


Globally consistent data sets from 42 countries, each with the same level of detail.


All models, approaches, inferences, and sources behind our data sets available for review.

The EpicOncology™ Platform

Your Insight Into Cancer Epidemiology

With the right clinical data sets, you can do more than just respond to cancer’s global spread. You can anticipate it. Get in front of it. Save thousands with new treatments.

Readily available, detailed epidemiology data. Available on-demand in formats you can incorporate into your own R&D. Built by a team of experts to empower your research results.

This is more than just a set of numbers. This is insight. This is power to make a change. This is Epic.

The EpicOncology™ Dataset

the most comprehensive cancer epidemiology source available
of all cancer types represented
of global cancer
subtypes/biomarkers from 55 cancer sites
countries with consistent oncology analyses

Unmatched Access to Lifesaving Cancer Data

our insight IS your advantage
Transparent Oncology Data

Ensuring your trust and understanding of our process and methodologies through complete transparency of data and our models.

Cancer Data Reports in Epic Interface

The EpicOncology™ interface receives continuous updates, with new data and functionality to make your experience better.

Supporting Oncology Research Efforts

Does a better method exist to integrate EPIC data into your research process? We’ll help you find it.  

Ready for a demonstration?

Let us show you how EpicOncology™ will change how you see cancer data.
Cancer Data Insights from Epiphany Team

We Are Epiphany.

Field leaders in cancer epidemiology. Each of our epidemiology team members have worked in cancer research and epidemiology for more than 30 years. EpicOncology™ is our core product.

As an “Epiphany Partner,” you have access to not only our epidemiology data. Collaborate with our epidemiology experts to tailor data for your specific needs. Derive actionable intelligence for making a real difference in research, treatments, and breakthroughs.

Like our name states, we want you to gain insight from our collaboration. Make better, faster, more strategic decisions. Have an “Epiphany” on the future of cancer treatment.

epiphany memberships and affiliations

Client Testimonials

  • Roger, thank you VERY MUCH for quickly delivering the results. I have reviewed the method and the results. They look perfect.

    J.H., Epidemiologist
  • I know I keep saying this, Shelley, but your interface is head and tails above the rest. It’s so easy to use!

    R.J., Associate Director, Global Forecasting
    Top 20 Pharmaceutical Company
  • We really did appreciate your time and your dedication to explain this complex topic and answer our questions. Hugely helpful. I can already report that I used the gained knowledge in a pitch to our VP clinical operations.

    M.H., Medical Affairs
  • Thanks a lot for your excellent insights and training today. It was good to see the vast data and potential of EpicOncology™.

    S.S., Director, Global Marketing
    Top 10 Pharmaceutical Company
  • Thank you very much for updating these estimates and the deep dive on the conversion of AJCC 7th edition to the 8th edition. I appreciate the detailed information provided to explain the differences in the staging and conversion. This is very helpful.

    S.P., Principal Scientist
  • You are incredible!! Thank you so much for pulling the transitional cell analysis and assumptions (which makes sense) together … to do so over the weekend is an added surprise. This helps tremendously.

    P.T., Pharmacoepidemiologist
    Top 10 Pharmaceutical Company